215 related articles for article (PubMed ID: 15284260)
1. Differential prognostic impact of comorbidity.
Read WL; Tierney RM; Page NC; Costas I; Govindan R; Spitznagel EL; Piccirillo JF
J Clin Oncol; 2004 Aug; 22(15):3099-103. PubMed ID: 15284260
[TBL] [Abstract][Full Text] [Related]
2. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
3. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
5. Importance of comorbidity in hypopharyngeal cancer.
Homma A; Sakashita T; Oridate N; Suzuki F; Suzuki S; Hatakeyama H; Mizumachi T; Taki S; Fukuda S
Head Neck; 2010 Feb; 32(2):148-53. PubMed ID: 19536763
[TBL] [Abstract][Full Text] [Related]
6. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival.
Tammemagi CM; Neslund-Dudas C; Simoff M; Kvale P
J Clin Epidemiol; 2004 Jun; 57(6):597-609. PubMed ID: 15246128
[TBL] [Abstract][Full Text] [Related]
7. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
[TBL] [Abstract][Full Text] [Related]
10. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
11. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
Saito T; Hara N; Kitamura Y; Komatsubara S
Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
14. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
Adolfsson J; Tribukait B; Levitt S
Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode.
Birim O; Kappetein AP; Waleboer M; Puvimanasinghe JP; Eijkemans MJ; Steyerberg EW; Versteegh MI; Bogers AJ
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):491-8. PubMed ID: 16935100
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity in older surgical cancer patients: influence on patient care and outcome.
Janssen-Heijnen ML; Maas HA; Houterman S; Lemmens VE; Rutten HJ; Coebergh JW
Eur J Cancer; 2007 Oct; 43(15):2179-93. PubMed ID: 17681780
[TBL] [Abstract][Full Text] [Related]
17. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
18. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
19. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting.
Kastner C; Armitage J; Kimble A; Rawal J; Carter PG; Venn S
Prostate Cancer Prostatic Dis; 2006; 9(3):270-4. PubMed ID: 16770340
[TBL] [Abstract][Full Text] [Related]
20. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index.
Janssen-Heijnen ML; van Spronsen DJ; Lemmens VE; Houterman S; Verheij KD; Coebergh JW
Br J Haematol; 2005 Jun; 129(5):597-606. PubMed ID: 15916681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]